Stockreport

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]

PepGen Inc.  (PEPG) 
PDF – FREEDOM2-DM1 5 mg/kg cohort on track to readout in Q1 2026, with all patients enrolled and having received at least one dose – – Recent $115 million financing exten [Read more]